Shopping Cart 0
Cart Subtotal
AED 0

Centers for Disease Control and Prevention - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

Centers for Disease Control and Prevention (CDC) a subsidiary of US Department of Health and Human Services is a public health institute that offers health, safety and security threat management solutions. The institute provides health information to fight diseases and support communities from expensive and dangerous health threats. It offers services in the areas of attention-deficit hyperactivity disorder, cancer, diabetes, heart disease, flu, and sexually transmitted diseases. CDC also offers laboratory safety services by conducting scientific research. The institute has collaboration with schools and universities, business, labor, public health associations, industries, international health organizations and others to prevent human health. CDC is headquartered in Atlanta, Georgia, the US.

Centers for Disease Control and Prevention-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Centers for Disease Control and Prevention, Medical Devices Deals, 2012 to YTD 2018 10

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Abeome Enters into Research Agreement with Centers for Disease Control and Prevention 12

Synthetic Biologics Enters into Research Agreement with Centers for Disease Control and Prevention 13

GeoVax Labs Enters into Research Agreement with Centers for Disease Control and Prevention 14

Centers for Disease Control and Prevention Enters into R&D Agreement with Nanomedical Diagnostics 15

CDC Foundation Enters into Agreement with Pfizer and Centers for Disease Control and Prevention 16

uBiome Enters into Research Agreement with Centers for Disease Control and Prevention 17

Accelerate Diagnostics Enters into Co-Development Agreement with Centers for Disease Control and Prevention 18

Licensing Agreements 19

Biological E Receives Vaccine Technology from Centers for Disease Control and Prevention (CDC) 19

Centers for Disease Control and Prevention-Key Competitors 20

Centers for Disease Control and Prevention-Key Employees 21

Centers for Disease Control and Prevention-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 23

Legal and Regulatory 23

Apr 18, 2018: WMH Earns CDC Recognition for Diabetes Prevention Program 23

May 12, 2017: AHF Affiliate AID Atlanta Files Federal Lawsuit Against CDC for Defunding Respected Longtime AIDS Service Provider 24

Jan 04, 2017: New Antimicrobial Stewardship Standard issued for US hospitals to fight antimicrobial resistance 26

Government and Public Interest 27

Sep 25, 2018: U.S. Challenges World to Intensify Global Fight against Antibiotic Resistance 27

Sep 06, 2018: NIH taps OHSU to help improve reproductive health 29

Sep 04, 2018: UIC to lead study of negative pressure wound therapy in obese and diabetic patients 30

Sep 04, 2018: Cdc releases guideline to improve care of children with mild traumatic brain injury 31

Aug 07, 2018: Babies with Zika-related Health Problems Continue to Need Attention 32

Jun 08, 2018: Reducing Opioids Not Associated with Lower Patient Satisfaction Scores, Kaiser Permanente Study Finds 34

Jun 07, 2018: American Association for Cancer Research Supports Goal of Eliminating HPV-related Cancers in the United States 35

May 10, 2018: UNC researchers discover how body temperature wrecks potential dengue, Zika vaccine 36

Jan 04, 2018: Key Findings: Study Shows That Regular Treatment to Prevent Bleeding Episodes Is Used Less Frequently Among Adults Than Children with Hemophilia B 38

Dec 19, 2017: NACDD Statement in Support of CDC's Clarification on Funding Priorities 40

Dec 04, 2017: CDC Awards ICF USD 9 Million Cancer Surveillance Task Order 41

Nov 30, 2017: Brain's Appetite Regulator Disrupted in Obese Teens 42

Nov 09, 2017: Alkermes Calls for Impartial National Review of Scientific Data Supporting the Use of FDA-Approved Treatment Options for Opioid Dependence 43

Sep 28, 2017: New study shows Tdap vaccination during pregnancy can prevent whooping cough in babies 44

Sep 11, 2017: Evolva awarded contract by US government to advance novel pest control product 45

Sep 11, 2017: New Study Reveals Hidden Burden of Lupus Among Hispanic and Asian Women in Manhattan 46

Sep 07, 2017: Progress has stalled in US stroke death rates after decades of decline 48

Aug 08, 2017: USD 15 Million Grant to LSUHealthNO to Help Reduce Cancer in Louisiana 49

Aug 04, 2017: CDC invests more than USD 200 million to help states respond to infectious disease threats 50

Feb 01, 2017: US CDC updates recommendations on Candida auris 52

Jan 20, 2017: South African Study Provides Compelling New Evidence on Role of Person-to Person Transmission in Drug-Resistant TB Epidemics 53

Product News 54

Mar 08, 2018: CDI Labs Collaborates on Discovery of New Biomarkers for Zika Infection 54

Other Significant Developments 55

Oct 08, 2018: PointClickCare Joins Global Initiative to Combat Antimicrobial Resistance 55

Sep 21, 2018: Webb County, Texas, and two Teamsters Health & Welfare Funds Seek Federal Court injunction for top three pharmacy benefit managers to take immediate steps to address country's opioid crisis 57

Aug 15, 2018: 'BOOST-3' Trial Seeks to Improve Outcomes After Severe Traumatic Brain Injury 58

Jan 11, 2017: Karmanos Cancer Institute joins nation's leading cancer centers to endorse HPV vaccine 60

Appendix 61

Methodology 61

About GlobalData 61

Contact Us 61

Disclaimer 61


List Of Figure

List of Figures

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Centers for Disease Control and Prevention, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Key Facts 2

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Centers for Disease Control and Prevention, Deals By Therapy Area, 2012 to YTD 2018 9

Centers for Disease Control and Prevention, Medical Devices Deals, 2012 to YTD 2018 10

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Abeome Enters into Research Agreement with Centers for Disease Control and Prevention 12

Synthetic Biologics Enters into Research Agreement with Centers for Disease Control and Prevention 13

GeoVax Labs Enters into Research Agreement with Centers for Disease Control and Prevention 14

Centers for Disease Control and Prevention Enters into R&D Agreement with Nanomedical Diagnostics 15

CDC Foundation Enters into Agreement with Pfizer and Centers for Disease Control and Prevention 16

uBiome Enters into Research Agreement with Centers for Disease Control and Prevention 17

Accelerate Diagnostics Enters into Co-Development Agreement with Centers for Disease Control and Prevention 18

Biological E Receives Vaccine Technology from Centers for Disease Control and Prevention (CDC) 19

Centers for Disease Control and Prevention, Key Competitors 20

Centers for Disease Control and Prevention, Key Employees 21

Centers for Disease Control and Prevention, Subsidiaries 22

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Centers for Disease Control and Prevention, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Centers for Disease Control and Prevention (CDC) a subsidiary of US Department of Health and Human Services is a public health institute that offers health, safety and security threat management solutions. The institute provides health information to fight diseases and support communities from expensive and dangerous health threats. It offers services in the areas of attention-deficit hyperactivity disorder, cancer, diabetes, heart disease, flu, and sexually transmitted diseases. CDC also offers laboratory safety services by conducting scientific research. The institute has collaboration with schools and universities, business, labor, public health associations, industries, international health organizations and others to prevent human health. CDC is headquartered in Atlanta, Georgia, the US.

Centers for Disease Control and Prevention-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Centers for Disease Control and Prevention, Medical Devices Deals, 2012 to YTD 2018 10

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Abeome Enters into Research Agreement with Centers for Disease Control and Prevention 12

Synthetic Biologics Enters into Research Agreement with Centers for Disease Control and Prevention 13

GeoVax Labs Enters into Research Agreement with Centers for Disease Control and Prevention 14

Centers for Disease Control and Prevention Enters into R&D Agreement with Nanomedical Diagnostics 15

CDC Foundation Enters into Agreement with Pfizer and Centers for Disease Control and Prevention 16

uBiome Enters into Research Agreement with Centers for Disease Control and Prevention 17

Accelerate Diagnostics Enters into Co-Development Agreement with Centers for Disease Control and Prevention 18

Licensing Agreements 19

Biological E Receives Vaccine Technology from Centers for Disease Control and Prevention (CDC) 19

Centers for Disease Control and Prevention-Key Competitors 20

Centers for Disease Control and Prevention-Key Employees 21

Centers for Disease Control and Prevention-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 23

Legal and Regulatory 23

Apr 18, 2018: WMH Earns CDC Recognition for Diabetes Prevention Program 23

May 12, 2017: AHF Affiliate AID Atlanta Files Federal Lawsuit Against CDC for Defunding Respected Longtime AIDS Service Provider 24

Jan 04, 2017: New Antimicrobial Stewardship Standard issued for US hospitals to fight antimicrobial resistance 26

Government and Public Interest 27

Sep 25, 2018: U.S. Challenges World to Intensify Global Fight against Antibiotic Resistance 27

Sep 06, 2018: NIH taps OHSU to help improve reproductive health 29

Sep 04, 2018: UIC to lead study of negative pressure wound therapy in obese and diabetic patients 30

Sep 04, 2018: Cdc releases guideline to improve care of children with mild traumatic brain injury 31

Aug 07, 2018: Babies with Zika-related Health Problems Continue to Need Attention 32

Jun 08, 2018: Reducing Opioids Not Associated with Lower Patient Satisfaction Scores, Kaiser Permanente Study Finds 34

Jun 07, 2018: American Association for Cancer Research Supports Goal of Eliminating HPV-related Cancers in the United States 35

May 10, 2018: UNC researchers discover how body temperature wrecks potential dengue, Zika vaccine 36

Jan 04, 2018: Key Findings: Study Shows That Regular Treatment to Prevent Bleeding Episodes Is Used Less Frequently Among Adults Than Children with Hemophilia B 38

Dec 19, 2017: NACDD Statement in Support of CDC's Clarification on Funding Priorities 40

Dec 04, 2017: CDC Awards ICF USD 9 Million Cancer Surveillance Task Order 41

Nov 30, 2017: Brain's Appetite Regulator Disrupted in Obese Teens 42

Nov 09, 2017: Alkermes Calls for Impartial National Review of Scientific Data Supporting the Use of FDA-Approved Treatment Options for Opioid Dependence 43

Sep 28, 2017: New study shows Tdap vaccination during pregnancy can prevent whooping cough in babies 44

Sep 11, 2017: Evolva awarded contract by US government to advance novel pest control product 45

Sep 11, 2017: New Study Reveals Hidden Burden of Lupus Among Hispanic and Asian Women in Manhattan 46

Sep 07, 2017: Progress has stalled in US stroke death rates after decades of decline 48

Aug 08, 2017: USD 15 Million Grant to LSUHealthNO to Help Reduce Cancer in Louisiana 49

Aug 04, 2017: CDC invests more than USD 200 million to help states respond to infectious disease threats 50

Feb 01, 2017: US CDC updates recommendations on Candida auris 52

Jan 20, 2017: South African Study Provides Compelling New Evidence on Role of Person-to Person Transmission in Drug-Resistant TB Epidemics 53

Product News 54

Mar 08, 2018: CDI Labs Collaborates on Discovery of New Biomarkers for Zika Infection 54

Other Significant Developments 55

Oct 08, 2018: PointClickCare Joins Global Initiative to Combat Antimicrobial Resistance 55

Sep 21, 2018: Webb County, Texas, and two Teamsters Health & Welfare Funds Seek Federal Court injunction for top three pharmacy benefit managers to take immediate steps to address country's opioid crisis 57

Aug 15, 2018: 'BOOST-3' Trial Seeks to Improve Outcomes After Severe Traumatic Brain Injury 58

Jan 11, 2017: Karmanos Cancer Institute joins nation's leading cancer centers to endorse HPV vaccine 60

Appendix 61

Methodology 61

About GlobalData 61

Contact Us 61

Disclaimer 61


List Of Figure

List of Figures

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Centers for Disease Control and Prevention, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Key Facts 2

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Centers for Disease Control and Prevention, Deals By Therapy Area, 2012 to YTD 2018 9

Centers for Disease Control and Prevention, Medical Devices Deals, 2012 to YTD 2018 10

Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Abeome Enters into Research Agreement with Centers for Disease Control and Prevention 12

Synthetic Biologics Enters into Research Agreement with Centers for Disease Control and Prevention 13

GeoVax Labs Enters into Research Agreement with Centers for Disease Control and Prevention 14

Centers for Disease Control and Prevention Enters into R&D Agreement with Nanomedical Diagnostics 15

CDC Foundation Enters into Agreement with Pfizer and Centers for Disease Control and Prevention 16

uBiome Enters into Research Agreement with Centers for Disease Control and Prevention 17

Accelerate Diagnostics Enters into Co-Development Agreement with Centers for Disease Control and Prevention 18

Biological E Receives Vaccine Technology from Centers for Disease Control and Prevention (CDC) 19

Centers for Disease Control and Prevention, Key Competitors 20

Centers for Disease Control and Prevention, Key Employees 21

Centers for Disease Control and Prevention, Subsidiaries 22

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Centers for Disease Control and Prevention, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.